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Tondo,	  JCP,	  2000	  
  Nature	  of	  problem	  	  in	  clinical	  settings.	  
  Current	  Understanding	  about	  suicide	  behavior	  
(neurobiology)	  	  	  
  What	  can	  be	  done	  to	  deal	  with	  suicide	  in	  clinical	  settings	  
  Pharmacological	  management	  
▪  Diagnosis	  
▪  Pharmacological	  agents	  
Suicide	  is	  a	  global	  public	  health	  problem,	  	  
aﬀec5ng	  more	  than	  a	  million	  people	  every	  year	  
  	  >50%	  	  -­‐	  seen	  a	  physician	  in	  previous	  one	  
month1	  	  	  
  	  50%	  of	  	  had	  	  experience	  in	  psychotherapy	  	  
  1	  of	  every	  2	  psychiatrists	  	  lose	  a	  patient	  to	  
suicide	  across	  20	  	  years	  practice	  	  
	  	  	  
  Magnitude,	  
Predictability	  
  Uncertain	  etiology	  	  	  	  
  Heterogeneous	  	  
  Unreliable	  Risk	  
Assessment	  	  	  	  
  No	  speciﬁc	  treatment	  	  
  No	  evidence	  that	  it	  
can	  be	  prevented	  	  
	  ?defeat	  depression?	  program,	  UK.	  	  	  
US	  military	  using	  preven8ve	  program	  
  	  5-­‐6.5%	  in	  hospital;	  	  
  	  3	  to	  5.5%	  in	  psychiatric	  hospital	  and	  	  
 2%	  in	  general	  hospital	  Inpatient.	  Rate	  
  	  1%	  of	  all	  suicides	  in	  UK	  occurs	  in	  
inpatients	  facility	  2	  
1.Bowers	  L,	  Banda	  T,	  Nijman	  H.	  Suicide	  inside:	  a	  systema8c	  review	  of	  inpa8ent	  suicides.	  J	  Nerv	  Ment	  Dis.	  2010	  May;198(5):315-­‐28.	  Review	  


















During	  First	  Year	   Conversion	  to	  
psychosis	  	  
Prodromal	  (N=81,	  Signiﬁcant	  F/H	  of	  suicide	  &	  SUD	  
First	  Episode	  (N=	  87,	  P=short	  DUP)	  
















SMR	  	  for	  
suicide	  in	  ﬁrst	  
28	  days	  
SMR-­‐male	  
21,921	  F/u	  2	  years	  
suicde	  committed	  in	  1	  years	  
suicide	  committed	  in	  28	  days	  
SMR	  	  for	  suicide	  in	  ﬁrst	  28	  days	  
SMR-­‐male	  
Ho	  TP.	  	  The	  suicide	  risk	  of	  discharged	  psychiatric	  pa8ents.	  J	  Clin	  Psychiatry.	  2003	  Jun;64(6):702-­‐7	  
47%	  
Before	  ﬁrst	  F/U	  

  Individuals	  At-­‐risk	  	  
  Risk	  situation	  
  Risk	  factors	  	  
  ?mental	  disorders?	  >90%	  1	  
  >60-­‐70%	  mentally	  ill	  
experience	  Suicidality	  2	  
  20-­‐35%-­‐NO	  Mental	  Illness	  3,4,5	  
1.WHO, 2009; 2. Popali M 2006; 3.David Shaffer 1998, 4. Parkar 2009; 5. Shrivastava 2005 
Suicide	  behavior	  is	  not	  necessarily	  a	  correlate	  of	  	  mental	  illness:	  	  























symptoms	   Diagnostic	  	   Risk	  	  
Social	  and	  
psychological	  
experiences	  	  e.g	  
Abuse,	  Trauma	  
Biological	  Brain	  
Changes	  	   Vulnerability	  

	  
1.Chen	  TJ,	  Med	  Hypotheses.	  2006;66(5):1043-­‐4.	  	  
2.Anda	  RF,Eur	  Arch	  Psychiatry	  Clin	  Neurosci.	  2006	  Apr;256(3):174-­‐86.	  2005	  
Childhood	  Experience	  &	  the	  Expression	  of	  Gene8c	  Poten8al:	  What	  
Childhood	  Neglect	  Tells	  Us	  About	  Nature	  and	  Nurture?	  	  
  A	  cohort	  of	  	  2759	  of	  CSA	  
  Schizophrenia	  =	  	  2.8%	  Vs.	  1.4%	  	  	  	   	   	  
	  [Cutajar	  MC	  et	  al,,	  Archives	  Gen	  psychiatry	  2010	  Nov]	  
  Childhood	  sex	  abuse	  	  1,2	  	  
  Post	  traumatic	  stress	  
disorder	  3	  
  Childhood	  adversity	  4	  
  Early	  prolonged	  trauma	  	  
  Chronic	  exposure	  to	  
trauma,	  	  
  Neurobiology:	  	  Serotonin	  
hypofunction,	  HPA	  Axis	  5	  
  Overlap	  between	  
neurobiology	  of	  SB	  and	  
impulsivity	  
1.Maniglio	  RThe	  role	  of	  child	  sexual	  abuse	  in	  the	  etiology	  of	  suicide	  and	  non-­‐suicidal	  self-­‐injury.	  	  Acta	  Psychiatr	  Scand.	  2010	  Oct	  11.	  doi:	  10.1111/j.
1600-­‐0447.2010.01612.x;	  2.Roy	  A.	  Combination	  of	  family	  history	  of	  suicidal	  behavior	  and	  childhood	  trauma	  may	  represent	  correlate	  of	  increased	  suicide	  risk.	  
J	  Aﬀect	  Disord.	  2010	  Oct	  11;	  4.Lentz	  V,	  Robinson	  J,	  Bolton	  JM.	  	  Childhood	  adversity,	  mental	  disorder	  comorbidity,	  and	  suicidal	  behavior	  in	  schizotypal	  personality	  
disorder	  J	  Nerv	  Ment	  Dis.	  2010	  Nov;198(11):795-­‐801.	  
	  
	  Braquehais	  MD,	  Oquendo	  MA,	  Baca-­‐Garcia	  E,	  Sher	  L.	  Is	  impulsivity	  a	  link	  between	  childhood	  abuse	  and	  suicide?	  Compr.Psychiatry	  2010	  Mar-­‐Apr;51
(2):121-­‐129	  
	  
Bebbington	  PE,	  Cooper	  C,	  Minot	  S,	  Brugha	  TS,	  Jenkins	  R,	  Meltzer	  H,	  Dennis	  M.	  Am	  J	  Psychiatry.	  2009	  Oct;166
(10):1135-­‐40.	  	  








experience	  of	  ‘Trauma’	  
is	  a	  signiﬁcant	  
antecedent	  
www.dsm5.org	  
  Epidemiological,	  	  
  Phenomenological,	  	  
  Biological,	  	  




▪  Across	  diagnosis	  
▪  No	  diagnosis	  
▪  Severity	  of	  illness	  Vs	  
Severity	  of	  attempt	  
▪  Cluster	  B	  
▪  Suicide::	  subtype	  of	  
schizophrenia	  	  	  
▪  DSM-­‐5	  
(Meltzer	  &	  Okayli,	  19951).	  (Hawton,	  et	  al.,	  2005)2.	  	  	  















Stress	   Glia	  
twins	   family	  
adop8on	  
epigene8c	  associa8ons	  





DA-­‐dopamine,	  ADR-­‐adrenaline,	  5HT-­‐serotonine,OPI	  –	  opiates,	  GLU-­‐glutamate,	  WGAS-­‐whole	  genome	  associa8on	  study	  
Carl	  Ernst	  et	  al	  ?Suicide	  neurobiology,	  Progress	  in	  neurobiology	  89	  (2009)	  315-­‐333	  
Neurochemical,	  	  	  	  	  	  	  	  	  	  	  
5Ht,	  ACH,	  GABA,	  GLU,	  
ADR,	  DA,	  OPI	  
Genetics;	   	  	  	  	  	  	  
Twins,	  family,	  Adoption,	  
Association,	  
Epigenetics	  
system	  study;	   	  	  	  	  	  	  	  	  	  	  
Glia,	  Stress,	  Lipids,	  
Signaling	  	  
Future	  study,	   	  	  	  	  	  	  
WAGS,	  micro	  RNA,	  
Proteins	  study,	  Brain	  
circuitry	  
Neurobiology	  	  
Research	  n	  suicidology	  	  
  Uncovering	  markers	  	  	  
  Low	  sensitivity	  and	  
predictability	  	  
  Environmental	  factors.	  
  	  No	  formal	  neurobiological	  
consensus	  
  Indices	  of	  serotonergic	  NT	  
and	  risk	  	  	  
  The	  5	  Ht	  association	  	  
-­‐?unspeciﬁc;	  
  mRNA	  proteins,	  -­‐	  dismissed,	  	  
  GABAergic	  and	  glutaminergic	  
dysfunction	  
  Etiological	  heterogeneity	  	  
  Endophenotypes	  
  White	  matter	  volume	  
















gene	  variants	  	  	  
Physiology	  &	  Behavior	  92	  (2007)	  245	  –	  249	  	  
  Cluster	  B	  traits	  and	  impulsive	  behavior	  represent-­‐	  intermediate	  



























McGIRR	  ET	  AL,	  Am	  J	  Psychiatry	  166:10,	  October	  2009	  
What	  is	  inherited?	  	  
  	  Additive	  genetic	  factors	  	  
  Estimated:	  30%	  to	  50%	  for	  a	  broad	  phenotype	  of	  suicidality	  
that	  includes	  ideation,	  plans,	  and	  attempts	  	  	  
  Largely	  independent	  of	  the	  inheritance	  of	  psychiatric	  
disorder	  [1]	  
  	  Heritability	  estimates	  of	  17%	  to	  45%-­‐	  	  Nonfatal	  suicide	  
attempts	  ,	  even	  after	  controlling	  for	  psychiatric	  disorder	  [2]	  	  
Voracek	  M,	  Loibl	  LM	  (2007):	  Gene8cs	  of	  suicide:	  A	  systema8c	  review	  of	  twin	  studies.	  Wien	  Klin	  Wochenschr	  119:463–	  475.5.	  Brent	  DA,	  Melhem	  N	  (2008):	  
Familial	  transmission	  of	  suicidal	  behavior.	  Psychiatr	  Clin	  North	  Am	  31:157–177.	  
Impulsive	  
behavior	  




1.  Association	  with	  illness	  in	  population;	  	  
2.  Heritable	  (20%	  or	  greater);	  	  
3.  Primarily	  state-­‐independent;	  	  
4.  Illness	  and	  endophenotype	  co-­‐segregate	  within	  
families	  (linkage	  of	  trait	  to	  gene	  variant);	  and	  	  
5.  Found	  in	  nonaﬀected	  family	  members	  more	  
frequently	  than	  in	  the	  general	  population	  
	  Go\esmanII,GouldTD(2003):The	  endophenotype	  concept	  in	  psychiatry:	  Etymology	  and	  strategic	  inten8ons.	  Am	  J	  Psychiatry	  160:636	  –	  645	  
  	  Impulsive-­‐aggressive	  traits,	  	  
  Early	  onset	  of	  major	  depression,	  	  
  Neurocognitive	  function,	  	  	  
  Heightened	  cortisol	  response	  to	  social	  stress.	  
  Transcription	  	  	  
  Neuroprotection	  	  	  
  Glutamatergic	  and	  noradrenergic	  NT	  	  	  
  Stress	  and	  inﬂammatory	  responses	  	  	  
  Synthesis	  of	  glycoproteins	  
  Phenotypes	  of	  response	  and	  medication	  side	  eﬀects,	  	  	  
  Biological	  pathways	  	  
Brent	  D,	  Melhem	  N,	  Turecki	  G.	  Pharmacogenomics	  of	  suicidal	  events.	  Pharmacogenomics	  2010	  Jun;11(6):793-­‐807	  
	  
  Mood	  disorder,	  PTSD,	  SUD	  
  	  Suicide	  behavior	  [8],and	  	  Psychosocial	  stress	  	  [9]	  
  elevated	  suicidality	  independently	  of	  psychiatric	  diagnoses.	  	  
  biological	  marker	  [?]	  of	  suicidal	  	  	  
  	  increased	  BDNF	  due	  to	  Tx	  can	  facilitate	  neural	  integrity	  and	  	  






Sher	  LBrain-­‐derived	  neurotrophic	  factor	  and	  suicidal	  behavior.	  QJM.	  2010	  Nov	  4,	  	  De	  Luca	  V,	  Souza	  RP,	  Zai	  CC,	  Panariello	  F,	  Javaid	  N,	  Strauss	  J,	  et	  al.	  Parent	  of	  origin	  eﬀect	  and	  diﬀeren8al	  allelic	  expression	  of	  BDNF	  Val66Met	  in	  
suicidal	  behaviour.	  World	  J.Biol.Psychiatry.	  2010	  Aug	  23	  ,	  Dawood	  T,	  Anderson	  J,	  Barton	  D,	  Lambert	  E,	  Esler	  M,	  Hotchkin	  E,	  et	  al.	  Reduced	  overﬂow	  of	  BDNF	  from	  the	  brain	  is	  linked	  with	  suicide	  risk	  in	  depressive	  illness.	  


























  Past	  attempt	  
  Family	  history	  

  Target	  	  Subgroups	  
  	  Comprehensive	  
management,	  	  
  Risk	  assessment	  ,	  
  Continues	  
community	  care	  	  
  Monitoring	  
  	  Resources	  	  
Need	  for	  Community	  based	  
experiments	  in	  prevention	  






Low	  risk	  	  
Low 
suicidality 	  
  No	  evidence	  of	  therapeutic	  	  beneﬁt	  	  
  ADD	  Treatment	  emergent	  SD-­‐	  
polymorphism	  of	  genes	  :	  
  Transcription,	  Neuroprotection,	  NT-­‐	  Glum,	  NA	  
  Stress	  inﬂammatory	  response	  
Davis	  A,	  Gilhooley	  M,	  Agius	  M,	  Zaman	  R	  
Suicide	  risk	  and	  choice	  of	  an5depressant.	  Psychiatr	  Danub.	  2010	  Jun;22(2):358-­‐9	  
  Neuroprotection	  
  Lithium	  responsive	  endophenotype	  
  Genetic	  predisposition	  (basis)	  of	  lithium	  response	  
  Gene-­‐by-­‐	  environment	  	  
  Risk	  was	  lower.	  [1]	  by	  	  80%	  in	  18	  months	  and	  
sustained.	  [2]	  
1.Tondo	  L,	  Hennen	  J,	  Baldessarini	  R	  J	  
Lower	  suicide	  risk	  with	  long-­‐term	  lithium	  treatment	  in	  major	  aﬀec8ve	  illness:	  a	  meta-­‐analysis.	  Acta	  Psychiatr	  Scand.	  2001	  Sep;104(3):163-­‐72.	  
	  
2.Baldessarini	  RJ,	  Tondo	  L,	  Davis	  P,	  Pompili	  M,	  Goodwin	  FK,	  Hennen	  J.	  
Decreased	  risk	  of	  suicides	  and	  a\empts	  during	  long-­‐term	  lithium	  treatment:	  a	  meta-­‐analy8c	  review.	  Bipolar	  Disord.	  2006	  Oct;8(5	  Pt	  2):625-­‐39.	  
	  	  
	  	  	  No.	  of	  Studies	  	  	  	  	  	  	  N	  	  	  	  	  	  	  	  	  	  	  Risk	  w/	  	  	  	  	  	  Risk	  w/o	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Lithium*	  	  	  	  	  Lithium*	  
	  	  	  	  	  	  	  	  	  28	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  17,294	  	  	  	  	  	  	  	  	  0.27	  	  	  	  	  	  	  	  	  	  	  	  3.39	  
  Apparent	  risk	  reduction	  :	  9.20	  fold	  
	  	  *	  %	  /	  Year	  
	  	  	  	  	  	  	  	  	  
-­‐	  Tondo	  et	  al	  Neurobiology	  of	  Suicide	  1997	  
  Less	  eﬀective	  than	  lithium	  
  Anticonvulsants	  	  and	  suicide	  behavior	  	  
  The	  mode	  of	  action	  	  	  is	  
not	  known	  	  
  	  Antidepressant	  action,	  	  
  Cognitive	  functioning,	  	  
  Compliance,	  	  	  
  Insight,	  	  
  Negative	  symptoms	  	  
  Substance	  abuse,	  
	  
2.De	  Hert	  M,	  Correll	  CU,	  Cohen	  D.Do	  an8psycho8c	  medica8ons	  reduce	  or	  increase	  mortality	  in	  schizophrenia?	  A	  cri8cal	  appraisal	  of	  the	  FIN-­‐11	  
study.	  Schizophr	  Res.	  2010	  Mar;117(1):68-­‐74.	  Epub	  2010	  Jan	  12.	  
(Meltzer,	  et	  al.,	  2003).	  	  
  Normalization	  of	  central	  5-­‐HT	  
activity,	  	  in	  the	  prefrontal	  cortex,	  
through	  down-­‐regulation	  of	  central	  5-­‐
HT2A	  	  
  	  Increased	  availability	  of	  central	  5-­‐HT	  
(Spivak,	  et	  al.,	  2003).	  	  
  	  A	  little	  more	  eﬃcacious	  than	  zotepine	  and	  
risperidone	  but	  (?)	  	  	  
  	  Diﬀers	  more	  clearly	  in	  adverse	  eﬀects	  from	  other	  
SGA	  	  	  
  	  	  Most	  beneﬁcial	  proﬁle	  (	  Tiihonen	  et	  al.,	  2009	  	   	  	  
  [A	  critical	  appraisal	  of	  the	  FIN-­‐11	  study]	  [2]	  
	  
Clozapine	  versus	  other	  atypical	  an8psycho8cs	  for	  schizophrenia.	  
Asenjo	  Lobos	  C,	  Komossa	  K,	  Rummel-­‐Kluge	  C,	  Hunger	  H,	  Schmid	  F,	  Schwarz	  S,	  Leucht	  S.	  
Cochrane	  Database	  Syst	  Rev.	  2010	  Nov	  10;11:CD006633.	  
  Exacerbation	  of	  	  
psychosis	  
  Neurological	  and	  	  
	  	  	  other	  side	  eﬀects	  











Antipsychotic dose  
  It	  could	  also	  be	  that	  antipsychotics	  do	  not	  help	  to	  prevent	  
suicidal	  behaviour	  because	  suicide	  may	  be	  a	  partially	  
independent	  illness.	  	  
  Possible	  hypothesis:	  Decrease	  ,	  Increase,	  Do	  not	  
inﬂuence	  	  	  
  	  Several	  controlled	  studies	  have	  rejected	  a	  
negative	  inﬂuence	  	  	  
  	  Reduce	  the	  risk	  of	  suicide	  and	  suicide	  
attempts	  in	  schizophrenia.	  
	  	  
▪  Good	  	  
  Unipolar	  depression	  
  bipolar	  disorder,	  	  	  
▪  Moderate	  	  
  Schizophrenia	  
  Eating	  disorder	  




  Personality	  disorder	  
  Substance	  abuse	  
  comorbid	  conditions	  
  organic	  mental	  
disorder	  [case	  report]	  	  
  PTSD	  
Electro	  Convulsive	  Therapy	  
  Aﬀective	  disorder	  30%	  to	  80%	  
  Substance	  use	  disorder	  19	  %	  to	  60%	  
  Schizophrenia	  	  2%	  to	  14%	  
In	  Both	  major	  depression	  and	  BPD	  ,	  
suicide	  account	  for	  20%	  of	  death	  

  50,352	  cases	  in	  10	  years	  
  34891	  conﬁrmed	  suicide	  
  13331	  were	  in	  contact	  with	  mental	  health	  
services	  
  1851	  were	  currently	  inpatients	  




  Inpatient	  suicide	  reﬂects	  service	  quality	  1	  
  safe	  infrastructure,	  	  adequate	  monitoring,	  	  
  Regular	  risk	  assessment	  during	  recovery	  and	  
prior	  to	  granting	  leave,	  
  staﬀ	  training	  programs	  in	  management	  of	  risk,	  
1.Hunt	  IM,	  Kapur	  N,	  Webb	  R,	  Robinson	  J,	  Burns	  J,	  Turnbull	  P,	  Shaw	  J,Appleby	  L:	  Suicide	  in	  current	  psychiatric	  in-­‐pa8ents:	  a	  case-­‐control	  study.Psychol	  Med	  
2007,	  37:831-­‐837.	  
2.Pompili	  M,	  Lester	  D,	  Innamora8	  M,	  del	  Casale	  A,	  Girardi	  P,	  Ferracu8	  S,	  Tatarelli	  R:	  Preven8ng	  suicide	  in	  jails	  and	  prisons:	  sugges8ons	  from	  experience	  with	  
psychiatric	  in-­‐pa8ents.	  J	  Forensic	  Sci	  2009,	  54:1155-­‐1162.24.	  
3.	  Tishler	  CL,	  Reiss	  NS:	  Inpa8ent	  suicide:	  preven8ng	  a	  common	  sen8nel	  event.	  Gen	  Hosp	  Psychiatry	  2009,	  31:103-­‐109.	  
	  
  Improved	  staﬀ	  communication	  
  Observe	  ward	  exits;	  	  Improved	  
observation	  methods;	  	  
  Increased	  engagement	  and	  support,	  
First	  few	  days	  are	  high	  risk	  
?It	  is	  clearly	  challenging	  to	  achieve	  a	  balance	  between	  
patient	  safety	  and	  patient	  autonomy,	  
but	  the	  need	  to	  protect	  individuals	  from	  harm	  during	  a	  
time	  when	  they	  are	  supposedly	  in	  a	  safe	  
environment	  should	  be	  a	  principal	  objective	  of	  
mental	  health	  services?.	  
  Assessment	  	  
  Setting	  the	  goals	  
  Level	  of	  monitoring	  	  
  Risk	  factors	  	  
  Physical	  
environment	  
  Crisis	  intervention	  	  	  
  Psychological	  
intervention	  
  Pharmacotherapy	  	  
  Aggressive	  management	  	  
  Early	  introduction	  of	  Lithium	  or	  Clozapine	  
  Optimizing	  the	  dosage	  	  
  Ward	  infrastructure	  	  
Community	  with	  EI	  	   Community	  without	  EI	  
Rates	  	  of	  suicidal	  
ideation	  &	  attempt	  
56%	   39%	  
Previous	  attempt	   16%	   5%	  
Decrease	  in	  Rates	  after	  
ﬁrst	  clinical	  contact	  	  
Similar	  	   Similar	  	  
SUD	  	   High	  	   Low	  
Suicidal	  behaviors	  	   Low	   High	  
  Discharge	  process	  	  
  Side	  eﬀects	  	  
  Continuity	  of	  care	  
  	  Avoid	  typical	  
antipsychotics	  	  
  Medication,	  dose,	  
duration	  and	  
compliance	  	  
  Identify	  risk	  	  &	  
predictors	  
  Inpatient	  and	  post	  discharge	  suicide.	  
  Previous	  attempt	  and	  family	  history	  
  Psychopathological	  traits	  are	  inherited	  
  Not	  all	  suicide	  are	  due	  to	  mental	  illness	  
  Suicide	  as	  independent	  pathological	  
dimension	  
  Epigenetics,	  neuroptotection,	  plasticity	  
and	  serotonin	  are	  important	  
  Lithium	  and	  clozapine	  are	  good	  for	  
treatment	  
  Treat	  both	  mental	  illness	  and	  suicidality	  
Need for paradigm shift in 







Thank	  you	  	  
